Single-Probe Dual-Mode Biosensor for Cross-Validated Detection of cTnI in Myocardial Damage Evaluation
ACS Sensors · 2026
DOI: 10.1021/acssensors.6c01411 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Sensors, 2026. Verfasst von Xiangyi Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Drug Research and Development, Guangdong Engineering Research Center of Digital and Intelligent Quality Control of Traditional Chinese Med…. Hauptthemen laut MEDLINE: Troponin I, Biosensing Techniques, Myocardium. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Department of Education of Guangdong Province, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Myocardial damage (MD) is a leading cause of death in cardiovascular disease, and cardiac troponin I (cTnI) has emerged as the cornerstone biomarker for diagnosis and monitoring due to its exceptional cardiac specificity and strong correlation with the extent of myocardial necrosis. This study presents a novel dual-mode biosensor built around a rationally designed Fe-MIL-101/QDs/aptamer-G-quadruplex/Hemin (FQGH) probe that integrates dual catalytic functions for dual-mode signal transduction. The FQGH probe possesses both Fenton-like and peroxidase-like activities. These two catalytic functions are mechanistically distinct and independently generate electrochemiluminescence (ECL) and electrochemical (EC) signals, enabling dual-mode detection of cTnI. In the ECL mode, its Fenton-like activity generates hydroxyl radicals (•OH) to amplify the cathodic ECL emission of CdS QDs. In the EC mode, leveraging its peroxidase-like activity, the probe facilitates the conversion of hydroquinone to benzoquinone, which is then electrochemically reduced to produce a measurable current. By leveraging these two parallel catalytic pathways from a single probe, the platform minimizes signal crosstalk and enables inherent cross-validated detection of cTnI, significantly enhancing assay specificity in complex matrices. This biosensor achieves an ultra-low detection limit of 0.12 pg/mL (ECL) and 0.46 pg/mL (EC), excellent selectivity, and demonstrates strong correlation with enzyme-linked immunosorbent assay (ELISA) in both mouse myocardial injury models and human clinical samples. This work establishes a reliable cross-validated detection platform for cTnI and provides a generalizable design paradigm for multifunctional nanozyme-based dual-mode biosensors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Drug Research and Development, Guangdong Engineering Research Center of Digital and Intelligent Quality Control of Traditional Chinese Medicine, the Second Clinical Medical School (Guangdong Second Provincial…
- State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, Jiangsu210093, China.
- The Third Affiliated Hospital of Guangzhou Medical University , Guangzhou, Guangdong510150, China.
- Department of Cardiology, NHC Key Laboratory of Assisted Circulation and Vascular Diseases, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong510080, China.
- Laboratory of Flexible Electronics Technology, Center for Synthetic and Systems Biology, Tsinghua-Peking Center for Life Science, Department of Chemistry, Tsinghua University, Beijing100084, China.
ORCID-Profile: Duanping Sun
Förderung
- National Natural Science Foundation of China
- Department of Education of Guangdong Province
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Xu, X., Liao, M., Xie, K., Yu, Z., Fang, C., Zhao, T., Pan, J., Chen, G., Guo, Y., & Sun, D. (2026). Single-Probe Dual-Mode Biosensor for Cross-Validated Detection of cTnI in Myocardial Damage Evaluation. ACS Sensors. https://doi.org/10.1021/acssensors.6c01411
Vancouver
Xu X, Liao M, Xie K, Yu Z, Fang C, Zhao T, et al. Single-Probe Dual-Mode Biosensor for Cross-Validated Detection of cTnI in Myocardial Damage Evaluation. ACS Sensors. 2026. doi:10.1021/acssensors.6c01411
BibTeX
@article{Xu2026,
author = {Xu, Xiangyi and Liao, Mingang and Xie, Kaibin and Yu, Ziteng and Fang, Chenruo and Zhao, Tong and Pan, Jianbin and Chen, Gangdong and Guo, Yue and Sun, Duanping},
title = {Single-Probe Dual-Mode Biosensor for Cross-Validated Detection of cTnI in Myocardial Damage Evaluation},
journal = {ACS Sensors},
year = {2026},
doi = {10.1021/acssensors.6c01411}
}
EUVIMED